Huawei has been severely impacted by the sanctions imposed by america. Regardless of going through main points, the Chinese language big continues to advance its journey at its personal tempo, commonly launching new merchandise.
Persevering with the development, Huawei is predicted to launch its flagship P50 sequence smartphones early subsequent yr, as per the schedule. Now, a brand new report claims that together with the P50 sequence smartphones, the corporate may also launch a brand new pill.
The spotlight of the pill is that it will likely be operating the PadOS HongMeng working system, which because the identify signifies, has been designed particularly for pill gadgets. For many who are unaware, HongMeng is the Chinese language identify for Huawei’s personal HarmonyOS.
The pill in query is predicted to come back with a 12.9-inch OLED show, providing a 120Hz refresh price and ultra-narrow bezels surrounding the display screen. The physique of the gadget, made up of steel, will likely be skinny and light-weight.
EDITOR’S PICK: Huawei ban will price 5G “much more”, says Brazil Vice President
As for the processor, the gadget might come powered by the corporate’s personal Kirin 9000 chipset — the identical chipset that powers the Huawei Mate 40 lineup. The report mentions that the product will belong to the corporate’s MatePad lineup.
Ever since america cut-off Huawei’s entry to Google’s Android working system, the corporate boosted the event of its personal working system, which the corporate unveiled as HarmonyOS final yr. Not too long ago, it launched HarmonyOS 2.0, which is predicted to energy upcoming smartphones, tablets, and wearable gadgets from the Chinese language big.
ALWAYS BE THE FIRST TO KNOW – FOLLOW US!
